Status:
COMPLETED
Vitamin D Absorbance Study - Clinical Trial of the Absorbance of Nano Liquid D3
Lead Sponsor:
Inspired Life Medical, Inc.
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Vitamin D is a commonly available essential prohormone humans need to regulate blood calcium and has recently emerged as potentially helpful in combating severe COVID-19. Despite its importance, some ...
Eligibility Criteria
Inclusion
- Adults, ages 18-70 years old
- Either male or female
- Taking less than 2,000 IU of vitamin D daily as a supplement during the 30 days before starting the study
- Ability to swallow a pill of typical size or a liquid less than 1 mL daily for 30 days
- Ability to speak, read, and understand English
- Access to smart phone or smart device with internet access for study-related communications
- Ability to do 3 at-home vitamin D finger prick blood tests on 3 separate days. The kits and supplies will be given to you.
- Ability to drop off finished blood tests at a UPS store or UPS drop box, or schedule a UPS pickup at your home, on each of the same days as you do the blood tests
Exclusion
- Females who are pregnant
- Taking, on average, more than 2,000 IU of vitamin D daily within 30 days before the study
- Currently have COVID-19 infection
- History of COVID-19 infection or positive COVID-19 test in last 60 days
- People with a diagnosis of Cystic Fibrosis
- People with a diagnosis of Crohn's Disease
- People diagnosed with Celiac Disease
- People with known diagnosis or history of any kidney related disease Including, but not limited to: Chronic kidney disease; End stage renal disease; Polycystic kidney disease; Lupus nephritis; Kidney cancer, Alport syndrome; Amyloidosis; Goodpasture syndrome; and Wegener's granulomatosis
- People with known diagnosis or history of any liver related disease Including, but not limited to: Hepatitis A; Hepatitis B; Hepatitis C; Fatty liver disease; Cirrhosis of the liver; Liver cancer; Hemochromatosis; Wilson disease
Key Trial Info
Start Date :
March 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04885803
Start Date
March 26 2021
End Date
July 30 2021
Last Update
August 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inspired Life Medical Office
Le Sueur, Minnesota, United States, 56058